TDC
GILD icon

Thompson Davis & Co’s Gilead Sciences GILD Stock Holding History

Thompson Davis & Co’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$89K Buy
1,150
+550
+92% +$41.5K 0.19% 122
2018
Q2 		$43K Buy
600
+100
+20% +$7.06K 0.1% 219
2018
Q1 		$38K Sell
500
-125
-20% -$9.94K 0.1% 207
2017
Q4 		$45K Buy
625
+150
+32% +$11.4K 0.11% 196
2017
Q3 		$38K Buy
475
+199
+72% +$15.2K 0.07% 298
2017
Q2 		$20K Hold
276
– – 0.03% 465
2017
Q1 		$19K Hold
276
– – 0.03% 510
2016
Q4 		$20K Sell
276
-103
-27% -$7.66K 0.03% 497
2016
Q3 		$30K Hold
379
– – 0.05% 341
2016
Q2 		$32K Sell
379
-5,217
-93% -$463K 0.05% 326
2016
Q1 		$514K Buy
5,596
+5,309
+1,850% +$479K 0.77% 21
2015
Q4 		$29K Sell
287
-16
-5% -$1.67K 0.04% 360
2015
Q3 		$30K Sell
303
-1,346
-82% -$149K 0.04% 355
2015
Q2 		$193K Buy
1,649
+1,089
+194% +$119K 0.22% 99
2015
Q1 		$55K Buy
560
+61
+12% +$6.19K 0.07% 276
2014
Q4 		$47K Sell
499
-1,558
-76% -$161K 0.05% 291
2014
Q3 		$219K Buy
2,057
+1,082
+111% +$106K 0.28% 76
2014
Q2 		$81K Buy
975
+700
+255% +$54.5K 0.12% 204
2014
Q1 		$19K Sell
275
-1,641
-86% -$129K 0.03% 390
2013
Q4 		$144K Buy
+1,916
New +$133K 0.22% 115

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Thompson Davis & Co's GILD Position: Q3 2018 in Review

Thompson Davis & Co increased its Gilead Sciences (GILD) stake by 92% in Q3 2018, buying an estimated $41.5K and bringing the position to 1,150 shares worth $89K. The position accounts for 0.19% of the portfolio, ranked #122.

Thompson Davis & Co first reported a position in GILD in Q4 2013 and has held it in 20 quarters since. The position peaked at $514K in Q1 2016. 1,527 funds tracked by Wall St. Rank hold GILD as of Q3 2018.

  • Thompson Davis & Co held 1,150 shares of Gilead Sciences worth $89K as of Q3 2018.
  • Thompson Davis & Co bought 550 Gilead Sciences shares in Q3 2018, an estimated $41.5K.
  • Gilead Sciences made up 0.19% of Thompson Davis & Co's portfolio in Q3 2018, its #122 holding.
  • Thompson Davis & Co first reported a position in Gilead Sciences in Q4 2013 and has held it in 20 quarters since.
  • Thompson Davis & Co's Gilead Sciences position peaked at $514K in Q1 2016.
  • 1,527 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2018.

Based on Thompson Davis & Co's 13F filing for Q3 2018, filed 14 Nov 2018.